new Delhi . India is trying to make its own vaccine against the corona virus epidemic. Meanwhile, there is a relief news for the people of India. The Indian Council of Medical Research (ICMR) has written a letter to Bharat Biotech asking it to run Human Trial in a Fasc Track mode. COVAXIN), writing a letter asking him to complete the human testing process of the COVID19 vaccine using the Fasc Track method.
ICMR DG Balaram Bhargava has written a letter to the principal investigators of Bharat Biotech and Medical Colleges to expedite the testing process of the indigenous corona vaccine. This paper states that the process of human testing should be completed before August 15 so that clinical trial results can be launched on August 15.
The letter states that it is the first indigenous vaccine being developed by India and is one of the highest priority projects being monitored at the highest level of government. This vaccine is derived from SARS-CoV-2, which is isolated by the ICMR-National Institute. Pune-ICMR and BBIL are currently working on a pre-clinical as well as clinical trial of this vaccine.
It is worth noting that earlier a letter written by the ICMR DG to Bharat Biotech was leaked, which said that the vaccine should be ready by August 15. It stated that by 15 August the vaccine would require more time for public use. The letter states that please note that noncompliance will be viewed very seriously, so you are advised to make this project a top priority and meet the given deadline without any lapse.
India’s first indigenous vaccine Kovaxin (COVAXIN)
Recently, India’s leading vaccine manufacturer Bharat Biotech announced that it has made an effective vaccine Kovaxin (COVAXIN) against Corona. Not only this, ICMR has also approved Bharat Biotech Phase I and II of human trials. Bharat Biotech said in its official statement that it has prepared it in collaboration with the Indian Council of Medical Research, ie ICMR and the National Institute of Virology (NIV).
12 institutes selected for trial in the country
The Indian Council of Medical Research, i.e. ICMR, has selected 12 institutes for trials on the country’s first indigenous Kovid-19 vaccine humans. One of these institutions is located in Odisha while the others are located in Visakhapatnam, Rohtak, New Delhi, Patna, Belgaum (Karnataka), Nagpur, Gorakhpur, Kattankulatur (Tamil Nadu), Hyderabad, Arya Nagar, Kanpur (Uttar Pradesh) and Goa.
Leave a Reply